全文获取类型
收费全文 | 189篇 |
免费 | 12篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 14篇 |
基础医学 | 1篇 |
临床医学 | 40篇 |
内科学 | 36篇 |
神经病学 | 7篇 |
外科学 | 60篇 |
综合类 | 3篇 |
预防医学 | 5篇 |
药学 | 19篇 |
中国医学 | 1篇 |
肿瘤学 | 13篇 |
出版年
2024年 | 2篇 |
2023年 | 6篇 |
2022年 | 4篇 |
2021年 | 8篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 15篇 |
2017年 | 10篇 |
2016年 | 6篇 |
2014年 | 8篇 |
2013年 | 32篇 |
2012年 | 18篇 |
2011年 | 10篇 |
2010年 | 6篇 |
2009年 | 9篇 |
2008年 | 9篇 |
2007年 | 6篇 |
2006年 | 3篇 |
2005年 | 2篇 |
2004年 | 7篇 |
2003年 | 4篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 4篇 |
1999年 | 1篇 |
1995年 | 1篇 |
1992年 | 1篇 |
1984年 | 1篇 |
排序方式: 共有201条查询结果,搜索用时 15 毫秒
1.
Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines 总被引:1,自引:1,他引:0
Summary. Although several authoritative, evidence-based, guidelines for the prevention of venous thromboembolism (VTE) have been published, the use of VTE prophylaxis in routine clinical practice varies markedly. Even in orthopedic surgery, the indication for which prophylaxis is used most often, a significant proportion of surgeons do not use routine prophylaxis. When prophylaxis is used, guideline recommendations are often not followed. A number of factors may contribute to the under-use of guidelines. Physician-related factors include: a lack of awareness of, or familiarity with, the guidelines; a perception that VTE is not a significant problem or that VTE prophylaxis is ineffective; and concern about potential bleeding risks. The guidelines may also be perceived to be too complicated or difficult to apply in a routine manner. In addition, a lack of facilities or resources may also present a barrier to implementation of the guidelines. A number of strategies are being investigated in an attempt to improve compliance with guidelines for VTE prophylaxis. For example, the Investigators Against Thromboembolism (INATE) initiative has developed a simplified pocket guideline on VTE prophylaxis in orthopedic and trauma surgery in order to raise awareness of the current guideline recommendations. 相似文献
2.
Continued advances in the understanding and management of congenital heart disease (CHD) mean that over 90% of children born with CHD now survive to adulthood. This in turn results in greater numbers of adult patients presenting for medical and surgical care at non-specialist centres. A simple classification of adult congenital heart disease (ACHD) according to complexity can help clinicians to understand the implications of the specific cardiac anomaly encountered. Issues relating to the conduct of anaesthesia in ACHD patient include careful attention to euvolaemia, the preservation of sinus rhythm and cardiac output, and in complex patients, manipulating the balance between systemic and pulmonary blood flows. Additionally, effective antibiotic prophylaxis and the prevention of either excessive bleeding or thromboembolism are vitally important. It should not be forgotten that although many patients with simple or repaired cardiac lesions may be very well managed in a non-specialist unit, those with Eisenmenger’s syndrome or severe pulmonary hypertension have an extremely high risk of death in the perioperative period, and in all but life-threatening situations should always be managed within specialist centres. 相似文献
3.
An audit of the introduction of a protocol for thromboprophylaxis at caesarean section revealed over treatment of low risk women and the under treatment of high risk women. A routine computer generated risk assessment profile was introduced as part of a maternity information system. Reaudit showed a significant improvement in adherence to the thromboprophylaxis protocol in all risk groups. 相似文献
4.
Yueh-Ching Liu Ting-Kuo Chang Shih-Chia Liu Yung-Chang Lu 《Formosan Journal of Musculoskeletal Disorders》2013,4(3):72-75
Pulmonary embolism (PE) is a rare but serious complication following orthopedic surgery. Routine prophylaxis remains a controversial issue. The current study outlines the case of a 34-year-old male patient with delayed diagnosis of PE 15 days after arthroscopic reconstruction of anterior cruciate ligament (ACL) without thromboprophylaxis. He was diagnosed with acute coronary syndrome initially, but the symptoms could not be relieved after cardiac catheterization. However, PE was finally confirmed 3 days later, after serial examinations. An anticoagulant agent with enoxaparin was administered, which resulted in the relief of symptoms, and he was discharged after 18 days of hospitalization. The symptoms of PE can be similar to those of acute coronary syndrome. Thus, establishing an accurate diagnosis is difficult due to the very low incidence of PE after ACL reconstruction. Some of the possible causes of PE in this patient were his history of smoking, obesity, and surgery with prolonged surgical and tourniquet times. Surgeons should be aware of and pay greater attention to this rare complication after arthroscopic ACL reconstruction, even for young and relatively healthy patients. 相似文献
5.
《British journal of haematology》2017,178(1):162-170
The National Venous Thromboembolism Prevention Programme was launched in England, in 2010. Its central objective was to reduce morbidity and mortality from preventable deep vein thrombosis and pulmonary embolism through introduction of a comprehensive systematic approach. The cornerstone of the programme was the introduction of mandatory documented risk assessment for venous thromboembolism, supported by national thromboprophylaxis guidance. Despite widespread uptake of risk assessment, measuring the impact of the national programme on outcomes has proved challenging. The aim of this paper is to review the implementation and outcomes of the national programme. 相似文献
6.
7.
8.
Tazi Mezalek Zoubida Abderahim Azzouzi Wafaa Bono Rajae Tachinante Mamoun Faroudy Lamiaa Essaadouni Chakib Nejjari 《Thrombosis research》2014
Introduction
No data are available on thromboprophylaxis use in Morocco. Our aim was to characterize patients at risk of venous thromboembolism and assess the rate of appropriate thromboprophylaxis.Materials and Methods
This was a national, observational, multicentre survey of venous thromboembolism risk and thromboprophylaxis use in hospitalized patients. Data were collected on a predefined date in three university hospitals in Morocco using a standardized pre-printed form. Thromboembolic risk was assessed according to the American College of Chest Physicians (ACCP) 2008 guidelines. Patients were classified as “thromboprophylaxis indicated” or “thromboprophylaxis not indicated”.Results
784 patients were analysed: 307 (39.2%) medical and 477 (60.8%) surgical. 421 (53.7%) were female. Medical patients were older than surgical patients (57.6 ± 11.5 vs. 46.2 ± 16.9 years, p < 0.0001) and were more likely to have risk factors for thromboembolism (50.5% vs. 45.7% of patients, p = NS). 57% of patients without contraindications or bleeding risk were at risk of thromboembolism according to ACCP guidelines and thromboprophylaxis was prescribed to 42.8% of these patients. In contrast, 7.4% of patients with no thromboembolic risk also received thromboprophylaxis (proportion agreement: 61.0%; Kappa = 0.296). Over half (54.5%) of medical patients at risk of thromboembolism did not receive thromboprophylaxis whereas 6.3% of those with no risk did receive it (proportion agreement: 76.4%; Kappa = 0.433). These figures were 57.9% and 9.2%, respectively, for surgical patients (proportion agreement: 52.7%; Kappa = 0.191). Thromboprophylaxis was given to 19.2% of patients with contraindications or a bleeding risk.Conclusions
Educational initiatives are imperative to inform doctors about appropriate thromboprophylaxis. 相似文献9.
The increasing incidence of thrombosis in hospitalized patients in the 21st century is due to improved awareness by clinicians and more sophisticated forms of imaging. Thromboprophylaxis is now an imperative in the NHS of the UK and this combined with new, improved and safer forms of anticoagulation means that postoperative deaths from venous thromboembolic disease should become a thing of the past. In the following paper the authors review the up-to-date literature with emphasis on the newer anticoagulants that do not require blood test monitoring. We fully accept that this is a developing field and that the recognized indications for certain of these agents will change with the accumulation of further evidence. 相似文献
10.